PharmaCyte Biotech (PMCB) Net Equity Issued and Repurchased (2011 - 2026)
PharmaCyte Biotech (PMCB) posted Net Equity Issued and Repurchased of -$86,419 for fiscal Q4 2026 (quarter ended Apr 30, 2026).
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends
For FY2026 (ended Apr 30, 2026), PharmaCyte Biotech's Net Equity Issued and Repurchased came in at $6.18 million.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 5.6% (FY2021 to FY2026).
- In prior fiscal years, PharmaCyte Biotech's Net Equity Issued and Repurchased was $70.00 in FY2024 (-92.0%), $880.00 in FY2023 (-100.0%) and $87.36 million in FY2022.
- The fiscal Q4 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased since fiscal Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | PharmaCyte Biotech | 3.79 Mn | -69.05 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -86,419.00 |
| Jan 31, 2026 | -401,625.00 |
| Apr 30, 2025 | -171,543.00 |
| Jan 31, 2025 | -3.95 Mn |
| Oct 31, 2024 | -10.74 Mn |
| Jul 31, 2024 | -10.17 Mn |
| Apr 30, 2024 | -10.70 Mn |
| Jan 31, 2024 | -7.04 Mn |
| Oct 31, 2023 | -1.51 Mn |
| Jul 31, 2023 | 8.54 Mn |
| Apr 30, 2023 | -4.31 Mn |
| Jan 31, 2023 | -3.78 Mn |
| Oct 31, 2022 | -3.39 Mn |
| Jul 31, 2022 | -2.09 Mn |
| Oct 31, 2021 | 87.36 Mn |
| Oct 31, 2020 | 2.84 Mn |
| Jul 31, 2020 | 1.82 Mn |
| Jan 31, 2020 | 450,000.00 |
| Oct 31, 2019 | 301,000.00 |
| Jul 31, 2019 | 582,500.00 |
API Access
PharmaCyte Biotech Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();